
Gilead Sciences Secures $3 Billion in Senior Notes to Boost Strategic Acquisition Firepower
Gilead Sciences, Inc.Description
What this story covers
Gilead Sciences raised $3 billion via senior notes for acquisitions. The laddered debt structure, $142.5M annual interest, and risks of leverage are discussed. Management's ability to generate returns on this capital is key.
Story snapshot
CompanyGilead Sciences, Inc.
TickerGILD
VariantStandard detailed
Duration5:18
Filing type8-K
PeriodN/A
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-064518
Sources1
Full Story Script
Content not available for this story.